Skip to main content

Table 1 Participant’s characteristics at inclusion and COVID-19 history

From: Resuming Training in High-Level Athletes After Mild COVID-19 Infection: A Multicenter Prospective Study (ASCCOVID-19)

Characteristics

F-NLR Rugby players, n = 779

Student athletes4, n = 171

Sex, male, n (%)

779 (100.0)

85 (49.7)

Age (years), mean (SD)

25.8 (4.6)

20.1 (3.1)

BMI (Kg/m2), median (Q1; Q3)

29.0 (27.1; 31.9)

22.3 (20.7; 23.7)

BMI > 30, n (%)

310 (39.8)

5 (2.9)

Ethnicity, n (%)

Afro-Caribbean

47 (6.0)

6 (3.5)

Caucasian

623 (80.0)

164 (95.9)

Melanesian Islands

109 (14.0)

Missing

1 (0.6)

Comorbidities, n (%)

Tobacco use

62 (8.4)

6 (3.5)

High blood pressure

2 (0.3)

0 (0.0)

Diabetes

0 (0.0)

1 (0.6)

Asthma

47 (6.1)

23 (13.5)

No comorbidity

675 (86.7)

142 (83.0)

Acute SARS-CoV-2 infection symptoms, n (%)

At least one symptom1

181 (23.7)

101 (59.1)

 1 symptom

90 (11.8)

14 (8.2)

 2 or 3 symptoms

59 (7.7)

36 (21.0)

  > 3 symptoms

32 (4.2)

51 (29.9)

No symptoms

580 (76.3)

70 (40.9)

Specific symptom: Ageusia/Anosmia

24 (3.2)

22 (12.9)

COVID(+) at inclusion (COVID(+)prevalent)2, n (%)

52 (6.7)

27 (15.8)

Known positive RT-PCR within 3 months prior to inclusion

15 (28.8)

17 (63.0)

Positive serology

49 (94.2)

27 (100.0)

COVID(+) during follow-up (COVID(+)incident), n (%)

206 (28.3)

NA

Positive RT-PCR

192 (93.2)

NA

Positive serology without previous positive PCR

 

NA

Among those with positive RT-PCR:

6.8)

 

 Seroconversion (+ serology after + PCR)

155 (80.7)

NA

 No seroconversion3

25 (13.0)

NA

  1. SD: Standard deviation; BMI: body mass index
  2. 1Including anosmia/ageusia, from Day 0 questionnaire
  3. 2Prevalent cases, previous positive SARS-COV-2 RT-PCR or serology
  4. 3Only 180/192 + PCR players with available samples for serology testing after + PCR
  5. 4The student population included representation from 27 sporting disciplines, predominant among which were rugby (16%), handball (13%), judo (11%), soccer (7%) and athletics (7%)